Press Releases | Boston Technology Review

Explore more publications!

Press Releases

Feb. 5, 2026

PathMaker Neurosystems Board Director, John Donoghue, Ph.D., Awarded 2026 Queen Elizabeth Prize for Engineering

GlobeNewswire, Inc.

EyePoint to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026

Feb. 5, 2026

EyePoint to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026

GlobeNewswire, Inc.

HYCU® Inks Technology Agreement with Assurestor to Power Modern Backup and Disaster Recovery Services

Feb. 5, 2026

HYCU® Inks Technology Agreement with Assurestor to Power Modern Backup and Disaster Recovery Services

GlobeNewswire, Inc.

ProMIS Neurosciences to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026

Feb. 4, 2026

ProMIS Neurosciences to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026

GlobeNewswire, Inc.

Global Intravascular Lithotripsy Market to Reach $3.8B by 2032 – iData Research

Feb. 5, 2026

Global Intravascular Lithotripsy Market to Reach $3.8B by 2032 – iData Research

EIN Presswire

Independent Research Analyzes How Creatio’s No-Code Agentic Platform Accelerates Public Sector Project Delivery by 88%

Feb. 4, 2026

Independent Research Analyzes How Creatio’s No-Code Agentic Platform Accelerates Public Sector Project Delivery by 88%

EIN Presswire

Xsolis Announces the Appointment of Vic Pierni as Chief Financial Officer

Feb. 18, 2026

Xsolis Announces the Appointment of Vic Pierni as Chief Financial Officer

GlobeNewswire, Inc.

WillWare Technologies Appoints Industry Leader Pranav Giridhar as Chairman of the Board to Drive Global Expansion

Feb. 3, 2026

WillWare Technologies Appoints Industry Leader Pranav Giridhar as Chairman of the Board to Drive Global Expansion

EIN Presswire

MedSEO Launches First GEO and SEO Firm Built Exclusively for Healthcare Amid 40M Daily Medical Queries to ChatGPT

Feb. 17, 2026

MedSEO Launches First GEO and SEO Firm Built Exclusively for Healthcare Amid 40M Daily Medical Queries to ChatGPT

GlobeNewswire, Inc.

Feb. 4, 2026

Cerence Delivers Strong Q1 FY26 Results, with Record-Setting Free Cash Flow, Adjusted EBITDA Above Guidance, and Accelerating Technology and Customer Momentum

GlobeNewswire, Inc.

Humanoid Robotics Market in 2026 Transformative Trends and Technological Advancements

Feb. 4, 2026

Humanoid Robotics Market in 2026 Transformative Trends and Technological Advancements

GlobeNewswire, Inc.

Feb. 17, 2026

Ataccama Named a Leader in 2026 Gartner® Magic Quadrant™ for Augmented Data Quality Solutions for the Fifth Consecutive Time

GlobeNewswire, Inc.

Feb. 17, 2026

Rhythm Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 26, 2026

GlobeNewswire, Inc.

Boston Pads Announces Partnership with Towne Realty Group, Expanding Access to Its Full-Stack Real Estate Ecosystem

Jan. 27, 2026

Boston Pads Announces Partnership with Towne Realty Group, Expanding Access to Its Full-Stack Real Estate Ecosystem

EIN Presswire

Feb. 3, 2026

Tango Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026

GlobeNewswire, Inc.

Future of Health (FOH) Research Displays How Partnerships Can Reduce Preventable Patient Harm

Feb. 3, 2026

Future of Health (FOH) Research Displays How Partnerships Can Reduce Preventable Patient Harm

EIN Presswire

Clarity Tattoo Removal Expands to MetroWest with Second Massachusetts Location in Framingham

Feb. 3, 2026

Clarity Tattoo Removal Expands to MetroWest with Second Massachusetts Location in Framingham

EIN Presswire

Akebia Therapeutics to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026

Feb. 4, 2026

Akebia Therapeutics to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026

GlobeNewswire, Inc.

BioCryst to Present at Upcoming Investor Conference

Feb. 17, 2026

BioCryst to Present at Upcoming Investor Conference

GlobeNewswire, Inc.

Feb. 3, 2026

BioCardia Announces Late Breaking Echocardiography Results from the CardiAMP HF Trial to be Presented at Technology and Heart Failure Therapeutics (THT)

GlobeNewswire, Inc.